Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-302338
Filing Date
2011-11-08
Accepted
2011-11-08 17:01:55
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d233804d10q.htm 10-Q 858577
2 SECTION 302 CEO CERTIFICATION d233804dex311.htm EX-31.1 8464
3 SECTION 302 CFO CERTIFICATION d233804dex312.htm EX-31.2 8591
4 SECTION 906 CEO CERTIFICATION d233804dex321.htm EX-32.1 2851
5 SECTION 906 CFO CERTIFICATION d233804dex322.htm EX-32.2 2866
  Complete submission text file 0001193125-11-302338.txt   2650769

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20110930.xml EX-101.INS 354831
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20110930.xsd EX-101.SCH 12244
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20110930_cal.xml EX-101.CAL 34139
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20110930_def.xml EX-101.DEF 76440
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20110930_lab.xml EX-101.LAB 83989
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20110930_pre.xml EX-101.PRE 83582
Mailing Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET 4TH FLOOR CAMBRIDGE MA 02139 6172995000
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 111188525
SIC: 2834 Pharmaceutical Preparations